openPR Logo
Press release

Personalized Immunotherapy Market to Hold a High Potential for Growth by 2028 | BriaCell Therapeutics, Gilead Sciences, Inc., Cellectis S.A.

01-15-2019 09:14 AM CET | Health & Medicine

Press release from: Future Market Insights

Personalized Immunotherapy Market to Hold a High Potential

Personalized immunotherapy is a biologic treatment for different type of cancer. Personalized immunotherapy boost the natural body defense system time to overcome with the cancer. Personalized immunotherapy uses the substance which are made up of human body or prepared in the laboratory to improve or restore the immune system of body. Personalized immunotherapy target to restore the immume system of human body to combat the cancer cell. Immune checkpoint blockade through anti-PD-1, PD-L1, and CTLA-4 inhibitors are the key substenaces which are used during the personalized immunotherapy. The most common used drugs for the personalized immunotherapy is Ipilimumab, Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, and Durvalumab. Personalized immunotherapy is mostly used to treat the leukemia, non-melanoma cancer, and more recently to treat mid-stage lung cancer. Only7 fraction of people are expected to show dramatic side effect after the personalized immunotherapy for treatment of cancer.

Request to View a Sample Copy of This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7844

Personalized Immunotherapy Market: Drivers and Restraints

Rising prevalence of leukemia and prostate cancer is the primary factor driving the growth of personalized immunotherapy market. Moreover, increasing funding by the government for the development of novel therapies for the treatment of cancer is expected to boost the personalized immunotherapy market over the forecast period. Additionally, rising focus of pharmaceutical companies to launch more improved drugs in the market for the treatment of cancer is also expected to fuel the growth of personalized immunotherapy market over the next decade. Also, the upsurge in treatment adoption in developing countries is anticipated to boost the revenue growth of personalized immunotherapy market. On other hand, high cost of drugs may hamper the growth of personalized immunotherapy market to some extent. Moreover, the lack of awareness among the people about the advance therapies for cancer treatment will also deter the growth of personalized immunotherapy market over the forecast period.  

Personalized Immunotherapy Market: Segmentation

The global Personalized Immunotherapy market is classified on the basis of product type, end user, and region.

Based on therapy type personalized immunotherapy market is segmented into following:

Monoclonal Antibodies

Non-specific immunotherapies

Cytokines

T-Cell Therapy

Cancer Vaccines

Based on application personalized immunotherapy market is segmented into following

Prostate Cancer

Brain Cancer

Breast Cancer

Leukemia

Others

Based on distribution channel personalized immunotherapy market is segmented into following:

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Personalized Immunotherapy Market: Market Overview

The global personalized immunotherapy market is expected to show significant growth over the forecast period due to the rise in funding by government for the development of novel drugs. According to GLOBOCAN, cancer burden has risen to 18.1 million cases and 9.6 million cancer deaths in 2017. GLOBOCAN also estimated than there has been 1.3 million cases of prostate cancer worldwide in 2017. By therapy type, monoclonal antibodies segment is expected to gain the maximum market share though immune checkpoint inhibitors most widely preferred for personalized immunotherapy. Prostate cancer segment by application is expected dominate the market by revenue due high adoption of personalized immunotherapy for the treatment of prostate cancer. Among all distribution channel hospital pharmacies is expected to be most dominant segment whereas retail pharmacies segment is anticipated show higher growth rate.

Personalized Immunotherapy Market: Regional Overview

On the basis of geography, Personalized Immunotherapy market is classified into eight key regions viz. North America, Latin America, Europe, APECJ, China, Japan, Middle East and Africa. North America is expected to dominate the global personalized immunotherapy market due to the rise in research and development for the development of novel drugs. After North America personalized immunotherapy market is then followed by Europe due to rising incidences of cancer in this region. APEC and China is the fastest growing region for global personalized immunotherapy market owing to rising number of contract research organization in this region. Latin America and Middle East and Africa is the least lucrative region for personalized immunotherapy market due to lack of awareness among the people about the advance therapies for the treatment of cancer.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/toc/rep-gb-7844

Personalized Immunotherapy Market: Key Players

Some of the key players found across the value chain of personalized immunotherapy market are BriaCell Therapeutics, Gilead Sciences, Inc., Cellectis S.A., Neon Therapeutics, Loxo Oncology. Bristol?Myers Squibb Company,  Merck & Co., Inc., F. Hoffmann-La Roche AG, Pfizer Inc., and AstraZenecaplc.

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Personalized Immunotherapy Market to Hold a High Potential for Growth by 2028 | BriaCell Therapeutics, Gilead Sciences, Inc., Cellectis S.A. here

News-ID: 1497797 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Personalized

Personalized Supplement Market Report- Top Players, Types, Applications and Regi …
The Personalized Supplement Market research report presents new recent developments, import-export analysis, trade regulations, value chain optimization, the impact of domestic and Personalized Supplement Market players, analyses opportunities in terms of emerging revenue pockets, and changes in market regulations. Personalized Supplement Market also highlights strategic market growth analysis, market size, category Personalized Supplement Market growths, product approvals, product launches, and geographic expansion in the Personalized Supplement Market. Download FREE PDF of
Prosperfit : your personalized financial fitness platform
We are Prosperfit, an organisation that is here to provide financial education through cognitive technology with our unbiased hand-holding. We are equipped to help individuals from a diverse background to become savvy and are equipped to choose the right action for their financial matters. Our personalised, secure, web based and mobile platforms help the users take the decision with ease and comfort. Prosperfit does not believe in taking commission from
TrendSights Analysis: Personalized Health
ReportsWeb.com published “Personalized Health Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Today's digitally savvy consumers are taking their personal wellbeing into their own hands by using products and services that address their specific health needs and help them "live better." As awareness increases, demand for more
Personalized Cancer Vaccines Market Personalized Cancer Vaccines Clinical Pipeli …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Personalized Vaccine: Trail Towards Cancer 1.1 Prologue to Personalized Cancer Immunotherapy 1.2 Advent of Personalized Cancer Vaccine 2. Perception of Personalized Vaccinomics 2.1 Genetic Heterogeneity by HLA System 2.2 Genesis of Tumor Neoantigens 3. Identification of Tumor Neoantigens 3.1 Conventional Methodologies 3.2 Next Genome Sequencing Approach 4. Development of Personalized Vaccines 4.1 Development
Personalized PCAP touchscreen design
Distec combines multi-touch foil with custom cover glass to create compact touch solutions in countless design variations Distec - leading German specialist for TFT flat screens and system solutions for industrial and multimedia applications - now offers touch screen displays with custom designed projected capacitive (PCAP) touchscreens. "Our modular, compact touch solutions are implemented according to customer requirements," explained Matthias Keller, COO Components at Distec. "Whether a custom colored print or
US Personalized Cancer Genome Sequencing Market
RNCOS has recently added a new Market Research Report titled, “US Personalized Cancer Genome Sequencing Market” to its report gallery. The US personalized cancer Whole-Genome Sequencing market is primarily classified into targeted genome sequencing and Whole-Genome Sequencing. Our report entitled “US Personalized Cancer Genome Sequencing Market” takes into account the Whole-Genome Sequencing services, i.e. one of the most attractive sectors due to its inherent capability of high revenue generation and